Mary Puma
Analyst · Needham & Company. Your question please
Thank you, Brian. With me today is Kevin Brewer, Executive Vice President and CFO; and Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. If you've not seen a copy of our press release issued earlier today, it is available on our Web site. Playback service will also be available on our Web site as described in our press release. Please note that comments made today about our expectations for future revenues, profits and other results are forward-looking statements under the SEC’s Safe Harbor provision. These forward-looking statements are based on management’s current expectations and are subject to the risks inherent in our business. These risks are described in detail in our Form 10-K Annual Report and other SEC filings, which we urge you to review. Our actual results may differ materially from our current expectations. We do not assume any obligation to update these forward-looking statements. Today Axcelis reported second quarter financial results with revenues of $64.5 million, gross margins of 39% and earnings per share of $0.10. As expected, our systems business returned to a more balanced mix between memory and foundry logic. The second quarter split was 37% memory and 63% foundry logic. We believe our systems business will have a bias towards foundry logic in the third quarter as well but will see increasing strength in memory activity beginning in the fourth quarter. We expect to end the year with systems revenues more evenly split between the two segments, similar to 2015. From a product perspective, Q2 saw a higher mix of high energy implants. In Q3, we expect a broader Purion product mix that will include the beginning of a significant uptick in medium current business. This increased activity is being driven by the technical differentiation of the Purion M, especially in the image sensor, RF and power device market. We expect Purion M revenues to be one of the key drivers of our market share increase in 2016. In terms of guidance, we continue to expect second half revenues to be stronger than the first half with momentum in the memory market increasing in Q4 and into 2017. For the third quarter, we are forecasting revenues of $65 million to $70 million, gross margins in the mid-30% range, operating income of $2.5 million to $3.5 million and an EPS of $0.03 to $0.06. Q3 gross margin guidance is impacted by the shipment of Purion M to new customers. This includes some Purion M systems built with higher cost inventory purchased prior to the volume ramp of the Purion platform, as well as systems with higher cost associated with the introduction of the first silicon carbide tool. It is also impacted by the expected closer of an outstanding Purion H evaluation. Revenues are lower than we had originally expected them to be at this point in the year. This has been driven by delays in customer spending at a few key accounts focused on memory. However, we continue to do a good job on executing against our primary objective of setting the table for 2017, with new Purion penetration. A key element of this objective is the extension of our base Purion product family to address the specific needs of customers producing not only memory devices but also image sensors and power devices. These extensions include, the new Purion EXE and VXE, providing the highest energy levels available in a production implanter, the high temperature Purion M with 150 mm silicon carbide capability for the power device market, and significant productivity and source life enhancements for the Purion H. In terms of customer penetrations in the first half of this year, we have added new customers both in memory and in foundry logic across all three types of Purion products. Our new penetrations are coming from expanding our customer base through new sales and evaluation placements, increasing the number of qualified recipes at existing customer sites, and securing capacity production buys as evaluations close. Interest continues to be very high in the Purion H due to the advantages the spot beam architecture provides for our customers' most challenging implant step. In Q2 we successfully added one new Purion H customer and shipped the first follow-on Purion H production system to a second DRAM manufacturer. We also extended an existing memory evaluation to give the customers' engineers more time to explore the capabilities of this system. We have shipped Purion XE to one new customer and two new fabs in both memory and foundry logic, including the first shipment of the Purion EXE in this quarter. The Purion EXE provides customers with a much higher energy capability in the same footprint as the Purion XE. Customers with the Purion XE can feel the upgrade to the EXE, giving them more flexibility in their buying decision. We are also seeing significant interest in the new Purion VXE which provides the highest energy levels available in a production implanter on the market today. We are seeing increased levels of interest from both the memory segment and the mature process technology segment for the standard Purion M at 200 and 300 mm wafer sizes. Low levels of metal contamination due to the hybrid filter design and better productivity at higher energy levels are driving this activity. Additionally, with the introduction of the high temperature Purion M with 150 mm silicon carbide capability, we are now seeing a ramp in shipment of these tools. We have also recently placed the standard 300 mm Purion M evaluation unit in a second fab of a leading Asian memory manufacturer to accelerate DRAM recipe qualification. Expanding our customer base keeps us on track to increase our market share to between 20% and 25% of the $825 million to $875 million implant market in 2016. This achievement positions us to take full advantage of multiple large projects anticipated in 2017 and '18. Customer fab projects over the next couple of years are expected to support the continued growth of the Internet of things and a large sustained memory build. New fab construction accounts for a significant portion of the implant TAM in a given year. A 100,000 wafer start fab requires between $150 million and $200 million of implant capacity. By splitting their business evenly between two strong implant suppliers, our customers have seen the innovation benefit as measured by productivity, yield and cost of ownership. As a result, Axcelis will see a step function increase in market share with just 30% to 50% participation in two to three of these new fab. Adding this incremental revenue to our existing customer base will allow us to achieve our 40% market share goal. Now I would like to turn it over to Kevin to discuss our gross margin improvement progress and our second quarter financial results. Kevin?